文献速递儿童神经与发育行为儿童感染

STXBP1脑病患儿的临床与遗传特征分析

[Clinical and genetic characteristics of children with STXBP1 encephalopathy].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2020-01-01

该研究回顾性分析15例STXBP1脑病患儿,发现发育迟缓和癫痫是主要独立表型,基因变异以新发错义为主,左乙拉西坦和氨己烯酸可能更有效控制癫痫发作。

要点

  • 发育迟缓和癫痫是STXBP1脑病主要独立表型,多数1岁内起病。
  • STXBP1基因变异以新发错义为主,发现5个未报道变异位点。
  • 左乙拉西坦和氨己烯酸可能较其他抗癫痫药更有效。

核心结论

  • 发育迟缓和癫痫是STXBP1脑病主要的、独立的临床表型特征。
  • STXBP1基因变异以新发错义变异为主。
  • 左乙拉西坦和氨己烯酸在控制癫痫发作方面可能更为有效。

研究设计与样本

  • 回顾性分析2014年1月至2019年6月首都儿科研究所附属儿童医院收治的15例STXBP1脑病患儿临床资料、基因变异及治疗转归。

主要发现

  • 15例中男11例、女4例,年龄2月龄至5岁9月龄,14例有癫痫伴发育落后,1例仅发育落后。
  • 癫痫起病年龄2日龄至19月龄,≤1岁发病11例,常见发作类型为强直和痉挛,7例诊断大田原综合征或婴儿痉挛症。
  • 11例间歇期脑电图异常包括多脑区癫痫样放电、爆发抑制及高峰失律,7例头颅MRI异常包括髓鞘化不良、脑白质容积少、胼胝体缺如或发育不全。
  • 随访2个月至4年9个月,3例癫痫发作完全缓解,6例部分缓解,5例无效;8例用左乙拉西坦6例有效,5例加用氨己烯酸4例有效。
  • 所有患儿均存在STXBP1基因变异,共15种类型:错义8例、无义1例、移码5例、复杂1例,5个未报道变异为c.1038_1039delCC、c.172delG、c.348_351dupTGAA、c.1193A>G、c.1769C>T。

临床怎么用

  • 对发育迟缓伴或不伴癫痫的患儿应警惕STXBP1脑病,尽早进行基因检测。
  • 癫痫发作可选用左乙拉西坦或氨己烯酸,尤其痉挛发作可考虑氨己烯酸。
  • 需长期随访发育行为,关注孤独症样表现。

局限性

  • 回顾性研究,样本量仅15例,随访时间不等,疗效判断需前瞻性大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical and genetic characteristics of developmental and epileptic encephalopathy (DEE) caused by syntaxin-binding protein 1 (STXBP1) gene mutation. Methods: The clinical data, gene variation and treatment outcome of 15 children with STXBP1 encephalopathy admitted to Children's Hospital Affiliated to Capital Institute of Pediatrics from January 2014 to June 2019 were analyzed retrospectively. Results: Among 15 patients, 11 were male and 4 were female, age ranged from 2 months to 69 months. The clinical manifestations of 14 children were epilepsy and developmental delay (DD) and the remaining one showed developmental delay without seizure. The onset age of epilepsy ranged from two days to 19 months and 11 of them experienced the first attack before 1 year of age. The common seizure types were epileptic spasms and tonic seizures. Seven patients were diagnosed with Ohtahara syndrome or West syndrome. Epileptic form discharges were observed in the interictal electroencephalograms (EEG) of 11 patients, including multifocal discharges, suppression-burst and hypsarrhythmia. The brain magnetic resonance imaging of 7 children were abnormal, including myelin dysplasia, less white matter, lack of corpus callosum or hypoplasia. The follow-up time ranged from 2 months to 57 months, after the last follow-up, 3 cases were seizure free, 6 children showed partial response and the other 5 patients had no response on multitherapy. Six of 8 patients showed good responses to levetiracetam (LEV) monotherapy or in combination with other antiepileptic drugs (AEDs). Vigabatrin (VGB) was applied to 5 patients with epileptic spasms and 4 of them showed response. All patients showed different degrees of developmental delay while four of them showed autistic features. STXBP1 gene mutations were identified in all cases and there were 15 types of gene variations, including 8 missense mutations, 1 nonsense mutation, 5 frame shift mutations and 1 complex mutation. Five novel mutations were unreported before, including c.1193A>G, c.172delG, c.1769C>T, c.1038_1039delCC, c.348_351dupTGAA. Conclusions: Development delay and epilepsy are the major and independent clinical phenotypes in children with STXBP1 encephalopathy. The variation of STXBP1 gene is mainly de novo. Levetiracetam and vigabatrin may be more effective in epilepsy control than other AEDs. 目的: 探讨突触融合蛋白结合蛋白1(STXBP1)基因变异所导致的STXBP1脑病患儿的临床特征及基因变异情况。 方法: 回顾性总结首都儿科研究所附属儿童医院2014年1月至2019年6月收治的15例STXBP1脑病患儿的临床资料,分析其遗传学病因及治疗转归情况。 结果: 15例患儿中男11例、女4例,年龄2月龄至5岁9月龄,其中14例患儿存在癫痫发作伴发育落后表现,1例仅表现为发育落后。癫痫发作起病年龄为2日龄~19月龄,≤1岁发病11例。常见的发作类型为强直、痉挛。7例患儿诊断为大田原综合征或婴儿痉挛症。11例癫痫患儿存在间歇期脑电图异常包括多脑区癫痫样放电、爆发抑制图形及高峰失律图形等。7例患儿存在头颅磁共振成像异常,包括髓鞘化不良、脑白质容积少、胼胝体缺如或发育不全等。随访2个月至4年9个月,3例癫痫发作完全缓解,6例部分缓解,5例无效。8例患儿单独或联合使用左乙拉西坦,6例有效。5例存在痉挛发作的患儿加用氨己烯酸,4例有效。15例患儿均存在不同程度的发育迟缓,4例患儿存在孤独症样表现。所有患儿均存在STXBP1基因变异,共有15种变异类型,其中错义变异8例、无义变异1例、移码变异5例、复杂变异1例。其中有5例患儿的变异位点未见报道,分别为c.1038_1039delCC、c.172delG、c.348_351dupTGAA、c.1193A>G、c.1769C>T。 结论: 发育迟缓和癫痫是STXBP1脑病主要的、独立的表型特征。STXBP1基因变异以新发错义变异为主。在控制癫痫发作方面,左乙拉西坦和氨己烯酸可能更为有效。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cao JJ, Ji XN, Mao YY, et al. [Clinical and genetic characteristics of children with STXBP1 encephalopathy]. Zhonghua Er Ke Za Zhi. 2020. PMID: 32521962. doi:10.3760/cma.j.cn112140-20191028-00683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。